Cargando…

PB2152: BIOLOGICAL AND CLINICAL CORRELATES OF GALECTIN-3 (GAL-3) EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

Detalles Bibliográficos
Autores principales:	Basic-Kinda, S., Ilic, I., Duletic-Nacinovic, A., Jonjic, N., Radman, I., Valkovic, T., Serventi-Seiwerth, R., Dujmovic, D., Dreta, B., Santek, F., Aurer, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431441/ http://dx.doi.org/10.1097/01.HS9.0000851436.36602.d4

Ejemplares similares

P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEM
por: Aurer, I., et al.
Publicado: (2022)

The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma
por: Duraković, Nadira, et al.
Publicado: (2021)

P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
por: Dragičević, Ida Hude, et al.
Publicado: (2022)

Multiple Myeloma Index for Risk of Infection
por: T, Valkovic, et al.
Publicado: (2018)

Serologic Responses Following Sars-Cov-2 Vaccination and Factors Influencing It in Patients with Hematological Malignant and Non-Malignant Diseases - a Prospective Multicentric Study
por: Sertić, Zrinka, et al.
Publicado: (2021)

Primary gastric mantle cell lymphoma
por: Petranovic, Duska, et al.
Publicado: (2012)

Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem
por: Sertić, Zrinka, et al.
Publicado: (2022)

Plasma Levels of Monocyte Chemotactic Protein-1 Are Associated with Clinical Features and Angiogenesis in Patients with Multiple Myeloma
por: Valković, Toni, et al.
Publicado: (2016)

Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma
por: Premužić, Vedran, et al.
Publicado: (2023)

Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017
por: Jakšić, Branimir, et al.
Publicado: (2018)

Plasma Levels of Osteopontin and Vascular Endothelial Growth Factor in Association with Clinical Features and Parameters of Tumor Burden in Patients with Multiple Myeloma
por: Valković, Toni, et al.
Publicado: (2014)

P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES
por: Galusic, D., et al.
Publicado: (2022)

PB2018: MULTIPLE MYELOMA WITH CENTRAL NERVOUS SYSTEM RELAPSE IN THE ERA OF NOVEL DRUGS - A MULTICENTER RETROSPECTIVE STUDY FROM THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGICAL MALIGNANCIES (KROHEM)
por: Mitrovic, Z., et al.
Publicado: (2022)

Unusual presentation of plasmablastic lymphoma involving ovarian mature cystic teratoma: a case report
por: Hadžisejdić, Ita, et al.
Publicado: (2017)

Significant Clinical Benefit of Pemetrexed-based Chemotherapy for Advanced Diffuse Malignant Peritoneal Mesothelioma: A Case Presentation
por: Peitl, Milena, et al.
Publicado: (2017)

Infections in Hospitalised Patients with Multiple Myeloma: Main Characteristics and Risk Factors
por: Valković, Toni, et al.
Publicado: (2015)

Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases
por: Galusic, Davor, et al.
Publicado: (2022)

Epstein-Barr virus-negative aggressive natural killer-cell leukaemia with high P-glycoprotein activity and phosphorylated extracellular signal-regulated protein kinases 1 and 2
por: Perkovic, Sanja, et al.
Publicado: (2012)

3’-Sulfo-TF Antigen Determined by GAL3ST2/ST3GAL1 Is Essential for Antitumor Activity of Fungal Galectin AAL/AAGL
por: Li, Yang, et al.
Publicado: (2021)

Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma
por: Štifter, Sanja, et al.
Publicado: (2010)

GINGIVAL ULCERATIONS IN A PATIENT WITH ACUTE MYELOID LEUKEMIA: A case report and literature review
por: Vučićević Boras, Vanja, et al.
Publicado: (2019)

Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases
por: Bašić-Kinda, Sandra, et al.
Publicado: (2021)

2152: Adipose tissue measurements of computed tomography scan studies as a possible predictor of cancer recurrence after radical prostatectomy
por: Ortiz, Ana I., et al.
Publicado: (2018)

PB2152: THE CLINICAL PICTURE OF CASTLEMAN DISEASE – A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Kanhai, Karan, et al.
Publicado: (2023)

Perindopril and a Galectin-3 Inhibitor Improve Ischemic Heart Failure in Rabbits by Reducing Gal-3 Expression and Myocardial Fibrosis
por: Li, Sha, et al.
Publicado: (2019)

PReS-FINAL-2152: Biomarkers as predictors of early inactive disease in children with juvenile idiopathic arthritis
por: Lavric, M, et al.
Publicado: (2013)

SAAV2152 is a single-stranded DNA binding protein: the third SSB in Staphylococcus aureus
por: Huang, Yen-Hua, et al.
Publicado: (2018)

2152. Detection of Uropathogens Using BD Kiestra™ Total Laboratory Automation with Urine Culture Application
por: Patel, Parul, et al.
Publicado: (2019)

Clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation
por: Xie, Hui, et al.
Publicado: (2021)

Structural Basis Underlying the Binding Preference of Human Galectins-1, -3 and -7 for Galβ1-3/4GlcNAc
por: Hsieh, Tung-Ju, et al.
Publicado: (2015)

2152. Epidemiology and Clinical Outcomes of Contemporary, Third-Generation Left Ventricular Assist Device (LVAD) Infections
por: Hershberger, Todd E, et al.
Publicado: (2018)

Purine Analogues Increase the Risk of Lethal and/or Prolonged COVID19 While Obinutuzumab Increases the Risk of Prolonged but Not Lethal Infection in Patients Treated for Lymphoid Malignancies -a Study of Krohem, the Croatian Group for Hematologic Diseases
por: Aurer, Igor, et al.
Publicado: (2021)

The Immunology of DLBCL
por: Takahara, Taishi, et al.
Publicado: (2023)

Galectin-3 and galectin-3 binding protein in rheumatoid arthritis
por: Ohshima, S, et al.
Publicado: (2003)

P1252: PREDICTING THE RESPONSE OF DLBCL CELLS TO BH3-MIMETICS USING SYSTEMS BIOLOGY
por: Cloete, I., et al.
Publicado: (2022)

Computational modeling of DLBCL predicts response to BH3-mimetics
por: Cloete, Ielyaas, et al.
Publicado: (2023)

TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptor
por: Raiter, Annat, et al.
Publicado: (2023)

Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies
por: Galili, Uri
Publicado: (2021)

Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma
por: Setayesh, Tahereh, et al.
Publicado: (2020)

2152. Activity of Imipenem/Relebactam Against Carbapenem-Resistant Non-Morganellaceae Enterobacterales (NME) in the United States – SMART 2019-2021
por: Lob, Sibylle, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hrrsm9tgh9un8rnn1iftorf1rv